323 results
Page 2 of 17
8-K
EX-99.1
yfn5mhwo
1 Nov 22
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key
7:05am
8-K
EX-99.1
6034uisccys 0jud
3 May 22
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key
7:16am
8-K
EX-99.1
u8qnai
8 Feb 22
Incyte Reports 2021 Fourth Quarter and Year-end Financial Results, and Provides 2022 Financial Guidance and Updates on Key Clinical Programs
7:17am
8-K
EX-99.1
oe6ztayfn8uebm
2 Nov 21
Corporate Statement Regarding Opzeluraâ„¢ (ruxolitinib) Cream
4:50pm
8-K
EX-99.1
z8qhal8x
2 Nov 21
Incyte Reports 2021 Third Quarter Financial Results
7:15am
8-K
EX-99.1
g9j5vz3molsq
3 Aug 21
Incyte Reports 2021 Second Quarter Financial Results
7:15am
8-K
EX-10.1
706yad6ty g99ns7
27 May 21
Departure of Directors or Certain Officers
4:06pm
DEFA14A
8n99 9bg6fxil98o7mj
14 May 21
Additional proxy soliciting materials
4:11pm
8-K
EX-99.1
7mhzemhzcyc6
4 May 21
Incyte Reports 2021 First Quarter Financial Results and Provides Updates on Key Clinical Programs
7:08am
8-K
EX-99.1
8ysafm4
9 Feb 21
Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on Key Clinical Programs
7:11am